Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene ...

Beqvez is a one-time AAV-based gene therapy designed to introduce in the transduced cells a functional copy of the factor IX ...

The personalised treatment, Tecartus also known as autologous anti-CD19-transduced CD3+, is a CAR-T therapy which uses the patient’s white blood cells which are then reengineered in a laboratory so ...

The Producer service offers customers a second option for accessing Asimov's technology for the cell and gene therapy ...

Direct cell reprogramming induces functional cDC1-like features in transduced cells within 3 days after expression of the transcription factors, and the process is complete after 9 days ...

Ahead of the FDA’s June target action date for Sarepta’s Duchenne muscular dystrophy gene therapy, ICER Chief Medical Officer David Rind blasted the regulator’s accelerated pathway in a JAMA viewpoint ...

German biotech Immatics has two major data readouts due 2H24, and a pivotal study initiation in melanoma - the risk reward is ...

Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ (fidanacogene elaparvovec-dzkt ...

Figure 1: Reconstitution of hematopoiesis with GFP-expressing peripheral-blood cell progeny in lethally irradiated mice after transplantation of GFP-transduced BM. Figure 2: Engraftment of BM ...

An in vitro screening process ensures that only those cells that have successfully been transduced or transfected by the ...

Across all runs, killing by the nsIL3-33mb15 construct against healthy CD34+ HPCs was below that of un-transduced control gamma-delta T cells. “INB-300 can selectively target leukemia cells ...

Protocol 2498: Phase I/II Study of Adoptive Immunotherapy with Virus Specific CD8+ T Cells that have been Transduced to Express a WT1-Specific T Cell Receptor for Patients with High Risk or Relapsed ...